In the present study we aimed to determine the effect of an AT-II antagonist candesartan on pancreatic microcirculation in an experimental model of acute necrotizing pancreatitis. Materials and methods: There were fi ve study groups with 10 animals in each. Pancreatitis was induced by intravenous infusion of cerulein and coadministration of glycodeoxycholate into biliopancreatic canal. Candesartan is given at 6th and 18th hour to the 24th and 48th hour groups, respectively. At 24th and 48th hours; following anaesthesia laparotomy was performed and laser Doppler fl owmetry was performed in the pancreatic tissue of the animals. Following scarifi cation blood samples were obtained for amylase, myeloperoxidase, IL-6 and tumour necrosis factor alpha. Tissue samples from the pancreas were obtained for histopathological analysis, endothelial cell apoptosis (TUNEL assay) and matrix metalloproteinase-9 immunohistochemistry. Results: Pancreatic microcirculation was higher in the candesartan treated groups (p < 0.05). Myeloperoxidase, IL-6 and tumour necrosis factor alpha was found to be lower in the candesartan treated groups (p < 0.05). The pancreatic edema and infl ammation were found to be reduced in the candesartan treated groups (p < 0.05). Endothelial apoptosis was found to be reduced by cadesartan treatment but it did not reach statistical significance (p > 0.05). Tissue matrix metalloproteinase -9 levels were found to be reduced with candesartan treatment (p < 0.05). Conclusion: Treatment with candesartan in the early phases of acute necrotizing pancreatitis effective on microcirculation of pancreatic tissue (Tab. 3, Fig. 6, Ref. 28). Text in PDF www.elis.sk.
Introduction
Microcirculatory dysfunction in the pancreas seems to have a critical role in the evolution of acute pancreatitis (1) . The pathophysiological changes of pancreatic microcirculation in acute pancreatitis (AP) are complex; they include vasoactive mediators, vasoconstriction, ischemia, etc. (2) . There is considerable evidence supporting ischemia as an initiating factor of pancreatic microcirculatory injury (3) . The vasoconstriction occurring in the early phase of AP may cause ischemia and stasis of the microcirculation (4) .
Matrix metalloproteinases (MMP) are effective in the late phase of the infl ammatory cascade. The MMP family is a group of zinc endopeptidases with different specifi cities for substrates of the extracellular matrix. A subgroup of these enzymes, which includes the type IV collagenases MMP-9 (gelatinase B) or MMP-2 (gelatinase A), has been shown to degrade some basement membrane components (5) . Neutrophils produce MMP on stimulation with trypsin being abundant in AP (6) .
The existence of an intrinsic renin-angiotensin system (RAS) in the pancreas has been previously suggested in the canine (7) . Angiotensin-I (AT1) and angiotensin-II (AT2) have been localized by immunochemistry to the endothelia and epithelia of the pancreatic vasculature and ductal system in the rodent pancreas. The pancreatic RAS may play a role for the regulation of pancreatic microcirculation and ductal secretion (8) . Angiotensin converting enzyme (ACE) inhibitors increase levels of the vasodilatory prostaglandins and nitric oxide which may be involved in the protective mechanism (9) .
In the present study, we assessed the effects of candesartan, an AT2 receptor antagonist, on pancreatic microcirculatory disorders and MMPs in the severity AP in rats.
Materials and methods

Animal models
We used 50 female Sprague Dawley rats weighing 280-340 g, housed in rooms maintained at 21 ± 1 °C and a 12-h dark cycle. Animals fasted overnight (12 h) before the experiment but had free access to water. Care was provided in accordance with the guidelines set by the ethics committee of Gazi University, Ankara, Turkey. Anasthesia was induced with intramuscular injection of ketamine (50 mg/kg; Ketalar, ECZACIBASI, Turkey) and intramuscular injection of xylazine hydrochloride (5 mg/kg; Rompun, BAYER; Germany). The right internal jugular vein was cannulated and the catheter was tunneled subcutaneously to the suprascapular area. Acute pancreatitis was induced by an intravenous infusion of cerulein (SIGMA ALDRICH; Germany) at 5μg/kg/h over 6 h superimposed on a standard infusion of 1.2 mL/kg glycodeoxycholic acid (10 mmol/L; SIGMA ALDRICH; GermanyY) into the biliary-pancreatic duct for 10 min at 30 mm Hg (10) .
Experimental protocol
The animals were randomly allocated into fi ve groups: Group I (n = 10), sham; Group II (n = 10), 24 h control group; Group III (n = 10), 48 h control group; Group IV (n = 10), 24 h candesartan group; Group V (n = 10), 48 h candesartan group. Animals in the 24 and 48 h control group were administered 2.5 mL saline orally via gavage method at 6 and 18 h following the induction of ANP, whereas animals in the 24 and 48 h candesartan group were administered a 2.5 mL of solution that contained 10 mg/kg candesartan orally via gavage method at 6 and 18 h following the induction of ANP. On day 1, the rats of 24 h control and 24 h candesartan groups and on day 2, the rats of 48 h control and 48 h candesartan groups were anesthetized and a re-laparatomy was performed. Pancreatic blood fl ow was measured in three different parts of pancreas by using laser Doppler fl owmeter (Perimed; Sweden). The mean values were calculated and presented as percent changes from basal values obtained in control rats (100 %). After the measurements blood was aspirated from the inferior caval vein for amylase, myeloperoxidase (MPO), IL-6 and tumor necrosis factor alpha (TNF-α). The pancreatic tissue was removed for microscopic evaluation and the animals were exsanguinated.
Biochemical analysis
Pancreatic amylase levels were measured using the ELISA kit (Immundiagnostic, Germany), IL-6 levels were measured by IL-6 ELISA kit (Biosource, Belgium), serum MPO levels were measured by ELISA kit (Hycult, Netherlands) and levels of TNF-α were measured via the use of the ELISA kit (Biosource, USA); all were according to the the protocol provided by the particular company.
Histopathological analysis
A portion of the pancreatic tissue from each rat was fi xed in 10 % neutral buffered formalin and embedded in paraffi n. One paraffi n section, stained with hematoxylin and eosin (H&E), was examined from each animal. One pathologist who was blinded to the treatment protocol scored the tissues for edema, acinar necrosis, infl ammatory infi ltrate, hemorrhage, fat necrosis, and perivascular infl ammation, in 20 different fi elds. The scores for each of the histologic abnormalities were added up (11) .
Endothelial cells apoptosis
Additional sections were prepared to establish the degree of endothelial cell apoptosis. The tissue samples were stained by the terminal deoxynucleotidyl transfer-mediated dUTP-biotin nick end labelling (TUNEL) method. The TUNEL assay for apoptotic cell detection was performed using the I.S. Cell Death Detection Kit (Chemicon; USA). Briefl y, 5 mm thick paraffi n embedded sections were incubated at 56 °C overnight. Following deparaffi nization and inactivation of endogenous peroxidase with 3 % hydrogenperoxidase, the slides were incubated with 20 mg/mL proteinase K (Sigma-Aldrich; Germany) for 15 min. The following steps were performed according to the manufacturer's instructions of TUNEL assay using Apoptag plus peroxidase in situ apoptosis detection. Finally, the slides were incubated with diaminobenzidine. Counterstaining of the specimens was done with 1 % methyl green for 10 min. Macrophages within germinal centre of tonsil were used as positive control. Each specimen was evaluated in light microscopy at high magnifi cation (x400). TUNEL positive cells were counted (12) . A qualifi ed pathologist blinded to the source of pancreatic tissue performed all measurements.
Immunohistochemical examination of pancreatic tissue MMP-9
4 μm paraffi n embedded pancreatic section was deparafi nized, mounted on poly-L-lysine-coated glass slides, and rehydrated in PBS. Endogenous peroxidase activity was blocked by incubation with 3 % H 2 O 2 /PBS for 10 min. After being immersed in goat serum blocking buffer at 37 °C for 1 hour, the specimens were incubated with mouse anti-rat MMP-9 monoclonal antibody at 4 °C overnight. The specimens were incubated with biotin conjugated goat anti-mouse secondary for 2 hours at room temperature, and then were incubated with ABC for 30 min. Finally,colouring reaction was performed with 3,3-diaminobenzidine and haematoxylin nucleus counter staining. Random observation of 5 high power microscopic views was used to evaluate staining results in each group. Brown staining cells were defi ned as MMP-9 positive expression cells (13) .
Statistical analysis
Statistical analysis was carried out using the SPSS 11.5 statistical program. The data are expressed as the mean ± SD. Statistical analysis of biochemical and histopathologic parameters was performed using the nonparametric Kruskal-Wallis H test, followed by the corrected Mann-Whitney U test, with a p value less than 0.05 considered to be statistically signifi cant.
Results
Microcirculatory values
Administration of candesartan signifi cantly improved the microcirculation of the pancreas in treated groups (p < 0.05) (Tab. 1, Fig. 1 ).
Biochemical analysis
Pancreatic amylase levels in the control and candesartan groups were signifi cantly higher than in the sham group (p < 0.05) (Tab. 1). Serum MPO levels in the 24 h and 48 h candesartan groups were signifi cantly higher than 24 h and 48 h control groups (p < 0.05) (Tab. 1, Fig. 2 ). Acute necrotizing pancreatitis caused a sig-nifi cant increase of serum IL-6 activity. Candesartan administration signifi cantly decreased this parameter in candesartan groups (p < 0.05) (Tab. 1, Fig. 3 ). Acute necrotizing pancreatitis caused a signifi cant increase of serum TNF-α level. Candesartan administration signifi cantly decreased this parameter in candesartan treated groups (p < 0.05) (Tab. 1, Fig. 4 ).
Histopathological analysis
The results of histopathologic analysis of pancreatic tissue for damage yielded that in the control groups it was higher compared with candesartan treated groups (both, p < 0.05). Histopathologic fi ndings are summarized in Table 2 and Figures 5A and 5B.
Endothelial cells apoptosis
Endothelial apoptosis was found to be reduced by cadesartan treatment but it did not reach statistical signifi cance (p > 0.05) (Tab. 3).
Pancreatic tissue MMP-9
Tissue MMP-9 levels were found to be reduced with candesartan treatment (p < 0.05) (Tab. 3, Fig. 6 ). 
Discussion
Today the pathogenesis of acute pancreatitis is understood as a disturbance of acinar cell integrity with local infl ammation, followed by a release of proinfl ammatory mediators into the circulation. By this, the local infl ammatory process triggers a systemic infl ammatory reaction (14) . The release of proinfl ammatory cytokines results into the activation of endothelial cells and increases the expression of adhesion molecules. Subsequently, pancreatic microcirculatory disorder with reduced parenchymal blood fl ow and increased leukocyte-endothelial interaction enables leukocyte extravasation into the tissue (15) . Microcirculatory disturbances are crucial in the progression of mild edematous to severe necrotizing pancreatitis and are accurate parameters for evaluating the severity of the disease (16) . Microcirculatory disturbances in AP comprise many components: decreased capillary blood fl ow and capillary density, increased capillary permeability, and enhanced leukocyte-endothelial interactions (17) . It is still not clear which of these factors is the initiating one or the most important. The improvement of pancreatic microperfusion should have a positive infl uence on microscopic alterations within the pancreas. Many reagents have been used for microcirculatory disorders. However the use of these substances in the clinical practice is limited. In the present study we aimed to determine the effect of an AT-II antagonist candesartan on pancreatic microcirculation in an experimental model of acute necrotizing pancreatitis. Capillary perfusion is altered further by changes in regional blood fl ow. Laser Doppler fl owmetry has shown progressive exclusion of capillaries from perfusion. The consequence of AP in rats was the reduction of capillary blood fl ow in the pancreas (18) . In this study pancreatic blood fl ow was measured by a laser Doppler fl owmeter and confi rms these data. Candesartan administration signifi cantly augmented capillary blood perfusion of pancreatic tissue.
Amylase is released from acinar cells during acute pancreatitis, and concentration in the serum is used to confi rm the diagnosis of pancreatitis (19) . In the present study the amylase levels were higher in the 24h control and 24h candesartan groups than other groups.
Pancreatic MPO activity, an indirect index of granulocyte infi ltration, was signifi cantly decreased in the candesartan treated groups. These results suggest that candesartan treatment in AP may reduce tissue destruction, proinfl ammatory cytokine response and pancreatic damage.
The serum marker IL-6 refl ects the severity of pancreatitis in the early course of the disease (20) . Pancreatic necrosis has been shown to increase the circulating levels of cytokines such as . In the present study, it was observed that IL-6 levels were signifi cantly higher in control groups. These results show that candesartan treatment may reduce pancreatic necrosis by improving pancreatic microcirculatory disorders in AP.
TNF plays a key role and is an important parameter that indicates the severity of AP (22) . It is known to mediate tissue damage through the activation of infl ammatory cells, upregulation of adhesion molecules, the production of nitric oxide, and the release of other cytokines and mediators of infl ammation (23) . Improving the pancreatic capillary blood fl ow may regulate proinfl ammatoryantiinfl ammatory response. We demonstrated that administration of candesartan in AP may increase pancreatic capillary blood fl ow and decrease activation of infl ammatory cells.
Acute pancreatitis is characterized by interstitial edema, vacuolization, infl ammation, and acinar cell necrosis (24) . Architectural changes to the microcirculation are also detectable within 30 min of the onset of infl ammation (25) . Histological changes in animal pancreatitis parallel fi ndings in humans. Microscopy demonstrates vessel wall media necrosis, with infi ltration of polymorphonuclear leukocytes, increased fenestration, micropinocytic vesicles and irregularity of the endothelial lining (26) . Improvement of microcirculatory disorders may reduce injury of the pancreatic tissue. In this study, administration of candesartan in AP reduced edema, infl ammation and acinar cell necrosis in pancreatic tissue.
The accumulation of infl ammatory cells and the release of infl ammatory factors after the occurrence of pancreatitis are factors that infl uence the disease process. There are many studies that support the fact that there is a close relationship between the apoptosis of pancreatic acinar cells and the severity of acute pancreatitis (27) . In our study the elevated apoptosis also closely correlated with the improvement of pancreatic blood fl ow. The results from our experiment support that apoptosis may change with improvement of pancreatic microcirculatory blood fl ow.
The inhibition of MMP-9 expression may lead to decrease granulocyte infi ltration and reduced exacerbated infl ammatory reaction in AP (15) . Our study has shown that candesartan decreases pancreatic tissue MMP-9 expression.
Consistent with our study, upregulation of pancreatic angiotensinogen may have a role for the regulation of tissue injury (28) . Inhibition of the AT 2 receptor could play a crucial role in the induction of infl ammation and in the impairment of microcirculatory regulation in the pancreas. Candesartan plays an important role in preventing the development and progression of acute necrotizing pancreatitis.
In conclusion; more dynamic and functional therapies should be developed that takes in to consideration the process of infl ammation and tissue damage. The AT 2 pathway seems to play central role in mediation of infl ammation, tissue damage and fi brosis; all of which are central in the pathogenesis of acute necrotizing pancreatitis. Therefore the results of the present study should be confi rmed with further studies and further by multicenter clinical trials.
